{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T01:05:55Z","timestamp":1783904755929,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":58,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-05014-9","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T01:36:12Z","timestamp":1778895372000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Low miR-223 links to major adverse cardiovascular and cerebrovascular events in end-stage renal disease through endothelial damage"],"prefix":"10.1186","volume":"27","author":[{"given":"Jie","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueling","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,16]]},"reference":[{"issue":"10","key":"5014_CR1","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1159\/000528560","volume":"53","author":"X Li","year":"2022","unstructured":"Li X, Lindholm B. Cardiovascular Risk Prediction in Chronic Kidney Disease. Am J Nephrol. 2022;53(10):730\u20139.","journal-title":"Am J Nephrol"},{"issue":"7","key":"5014_CR2","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.jcmg.2013.12.015","volume":"7","author":"A Hakeem","year":"2014","unstructured":"Hakeem A, Bhatti S, Chang SM. Screening and risk stratification of coronary artery disease in end-stage renal disease. JACC Cardiovasc imaging. 2014;7(7):715\u201328.","journal-title":"JACC Cardiovasc imaging"},{"issue":"9","key":"5014_CR3","doi-asserted-by":"publisher","first-page":"504","DOI":"10.14744\/AnatolJCardiol.2023.3443","volume":"27","author":"Y Temtanakitpaisan","year":"2023","unstructured":"Temtanakitpaisan Y, Saengnipanthkul S, Vutthikraivit W. Meta-Analysis of Prophylactic Renal Replacement Therapy after Cardiac Catheterization in Patients with Chronic Kidney Disease. Anatol J Cardiol. 2023;27(9):504\u201312.","journal-title":"Anatol J Cardiol"},{"issue":"21","key":"5014_CR4","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1161\/CIRCULATIONAHA.124.069217","volume":"149","author":"AF Hernandez","year":"2024","unstructured":"Hernandez AF, Udell JA, Jones WS, Anker SD, Petrie MC, Harrington J, et al. Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights From the EMPACT-MI Trial. Circulation. 2024;149(21):1627\u201338.","journal-title":"Circulation"},{"issue":"10041","key":"5014_CR5","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S0140-6736(16)30448-2","volume":"388","author":"BM Robinson","year":"2016","unstructured":"Robinson BM, Akizawa T, Jager KJ, Kerr PG, Saran R, Pisoni RL. Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices. Lancet (London England). 2016;388(10041):294\u2013306.","journal-title":"Lancet (London England)"},{"issue":"5 Suppl 3","key":"5014_CR6","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","volume":"32","author":"RN Foley","year":"1998","unstructured":"Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J kidney diseases: official J Natl Kidney Foundation. 1998;32(5 Suppl 3):S112\u20139.","journal-title":"Am J kidney diseases: official J Natl Kidney Foundation"},{"issue":"11","key":"5014_CR7","doi-asserted-by":"publisher","first-page":"657","DOI":"10.14744\/AnatolJCardiol.2023.3214","volume":"27","author":"KK K\u0131rbo\u011fa","year":"2023","unstructured":"K\u0131rbo\u011fa KK, K\u00fc\u00e7\u00fcksille EU. Identifying Cardiovascular Disease Risk Factors in Adults with Explainable Artificial Intelligence. Anatol J Cardiol. 2023;27(11):657\u201363.","journal-title":"Anatol J Cardiol"},{"issue":"11","key":"5014_CR8","first-page":"3717","volume":"25","author":"CL Meuwese","year":"2010","unstructured":"Meuwese CL, Halbesma N, Stenvinkel P, Dekker FW, Molanaei H, Qureshi AR, et al. Variations in C-reactive protein during a single haemodialysis session do not associate with mortality. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association -. Eur Ren Association. 2010;25(11):3717\u201323.","journal-title":"Eur Ren Association"},{"issue":"1","key":"5014_CR9","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12944-018-0771-z","volume":"17","author":"X Zhan","year":"2018","unstructured":"Zhan X, Chen Y, Yan C, Liu S, Deng L, Yang Y, et al. Apolipoprotein B\/apolipoprotein A1 ratio and mortality among incident peritoneal dialysis patients. Lipids Health Dis. 2018;17(1):117.","journal-title":"Lipids Health Dis"},{"issue":"2","key":"5014_CR10","first-page":"208","volume":"98","author":"AN Dunn","year":"2021","unstructured":"Dunn AN, Huded C, Raymond R, Lincoff AM, Bajzer C, Kapadia S, et al. Successful modeling of long term outcomes in end-stage renal disease patients undergoing percutaneous coronary intervention with drug-eluting stents. Catheterization Cardiovasc interventions: official J Soc Cardiac Angiography Interventions. 2021;98(2):208\u201314.","journal-title":"Catheterization Cardiovasc interventions: official J Soc Cardiac Angiography Interventions"},{"issue":"4","key":"5014_CR11","first-page":"100037","volume":"2","author":"GA Kristono","year":"2020","unstructured":"Kristono GA, Holley AS, Hally KE, Brunton-O\u2019Sullivan MM, Shi B, Harding SA, et al. An IL-6-IL-8 score derived from principal component analysis is predictive of adverse outcome in acute myocardial infarction. Cytokine: X. 2020;2(4):100037.","journal-title":"Cytokine: X"},{"issue":"3","key":"5014_CR12","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s13237-021-00378-9","volume":"64","author":"SG Roy","year":"2021","unstructured":"Roy SG. Regulation of autophagy by miRNAs in human diseases. Nucleus: Int J Cytol allied Top. 2021;64(3):317\u201329.","journal-title":"Nucleus: Int J Cytol allied Top"},{"issue":"5","key":"5014_CR13","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/sdi.13221","volume":"37","author":"J Jiang","year":"2024","unstructured":"Jiang J, Zhou M, Zhang Q, Shen H, Jia Y, Chen Y, et al. The Correlation Between Major Adverse Cardiovascular and Cerebrovascular Events (MACCE) and miR-142-3p in Maintenance Hemodialysis Patients With End-Stage Renal Disease. Semin Dial. 2024;37(5):373\u20139.","journal-title":"Semin Dial"},{"key":"5014_CR14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.atherosclerosis.2018.11.024","volume":"280","author":"M K\u00e9tszeri","year":"2019","unstructured":"K\u00e9tszeri M, Kirsch A, Frauscher B, Moschovaki-Filippidou F, Mooslechner AA, Kirsch AH, et al. MicroRNA-142-3p improves vascular relaxation in uremia. Atherosclerosis. 2019;280:28\u201336.","journal-title":"Atherosclerosis"},{"key":"5014_CR15","doi-asserted-by":"crossref","unstructured":"Chang RC, Joloya EM, Li Z, Shoucri BM, Shioda T, Blumberg B. miR-223 plays a key role in obesogen-enhanced adipogenesis in mesenchymal stem cells and in transgenerational obesity. Endocrinology. 2023;164(5).","DOI":"10.1210\/endocr\/bqad027"},{"issue":"5","key":"5014_CR16","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3892\/etm.2022.11280","volume":"23","author":"T Huang","year":"2022","unstructured":"Huang T, Xiao Y, Zhang Y, Wang C, Chen X, Li Y, et al. miR-223 ameliorates thalamus hemorrhage-induced central poststroke pain via targeting NLRP3 in a mouse model. Experimental therapeutic Med. 2022;23(5):353.","journal-title":"Experimental therapeutic Med"},{"issue":"6","key":"5014_CR17","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.3892\/etm.2021.10828","volume":"22","author":"S Yi","year":"2021","unstructured":"Yi S, Yang Y. Melatonin attenuates low shear stress-induced pyroptosis and endothelial cell dysfunction via the ROR\u03b1\/miR-223\/STAT-3 signalling pathway. Experimental therapeutic Med. 2021;22(6):1392.","journal-title":"Experimental therapeutic Med"},{"issue":"1","key":"5014_CR18","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1161\/CIRCRESAHA.121.319120","volume":"131","author":"MA Nguyen","year":"2022","unstructured":"Nguyen MA, Hoang HD, Rasheed A, Duchez AC, Wyatt H, Cottee ML, et al. miR-223 Exerts Translational Control of Proatherogenic Genes in Macrophages. Circul Res. 2022;131(1):42\u201358.","journal-title":"Circul Res"},{"issue":"1","key":"5014_CR19","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1186\/s12967-024-05480-5","volume":"22","author":"Z Ou","year":"2024","unstructured":"Ou Z, Cheng Y, Ma H, Chen K, Lin Q, Chen J, et al. miR-223 accelerates lipid droplets clearance in microglia following spinal cord injury by upregulating ABCA1. J translational Med. 2024;22(1):659.","journal-title":"J translational Med"},{"key":"5014_CR20","doi-asserted-by":"publisher","unstructured":"ElSharkawy M, Elsayed HM, Baki AH, Elbraky AA, Abd El-Mohsen MA, El-Rayes MO. Inflammatory markers in patients with ESKD on maintenance hemodialysis, hemodiafiltration (HDF), and early postkidney transplant patients and their relation to quality of life (SGA Score): TH-PO735. 2024;35(10S):https:\/\/doi.org\/10.1681\/ASN.2024tybypvvt.","DOI":"10.1681\/ASN.2024tybypvvt"},{"key":"5014_CR21","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ijcard.2015.06.120","volume":"198","author":"H Kim","year":"2015","unstructured":"Kim H, Kim KH, Ahn SV, Kang SW, Yoo TH, Ahn HS, et al. Risk of major cardiovascular events among incident dialysis patients: A Korean national population-based study. Int J Cardiol. 2015;198:95\u2013101.","journal-title":"Int J Cardiol"},{"issue":"1","key":"5014_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2174\/1573403X14666180711124825","volume":"15","author":"NG Vallianou","year":"2019","unstructured":"Vallianou NG, Mitesh S, Gkogkou A, Geladari E. Chronic Kidney Disease and Cardiovascular Disease: Is there Any Relationship? Curr Cardiol Rev. 2019;15(1):55\u201363.","journal-title":"Curr Cardiol Rev"},{"key":"5014_CR23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ncrna.2025.04.009","volume":"13","author":"E Brisot","year":"2025","unstructured":"Brisot E, Lepr\u00eatre PM, Hamza E, Fourdinier O, Brigant B, Ouled-Haddou H, et al. Uremic toxins levels are associated with miR-223 in chronic kidney disease-associated anemia. Non-coding RNA Res. 2025;13:121\u201330.","journal-title":"Non-coding RNA Res"},{"issue":"1","key":"5014_CR24","doi-asserted-by":"publisher","first-page":"4477","DOI":"10.1038\/s41598-019-41101-8","volume":"9","author":"O Fourdinier","year":"2019","unstructured":"Fourdinier O, Schepers E, Metzinger-Le Meuth V, Glorieux G, Liabeuf S, Verbeke F, et al. Serum levels of miR-126 and miR-223 and outcomes in chronic kidney disease patients. Sci Rep. 2019;9(1):4477.","journal-title":"Sci Rep"},{"key":"5014_CR25","doi-asserted-by":"crossref","unstructured":"Thum T. MicroRNA-223 made its way into vascular research. 2013;113(12):1270\u20131.","DOI":"10.1161\/CIRCRESAHA.113.302747"},{"key":"5014_CR26","doi-asserted-by":"publisher","first-page":"1187557","DOI":"10.3389\/fmed.2023.1187557","volume":"10","author":"M Shi","year":"2023","unstructured":"Shi M, Lu Q, Zhao Y, Ding Z, Yu S, Li J, et al. miR-223: a key regulator of pulmonary inflammation. Front Med. 2023;10:1187557.","journal-title":"Front Med"},{"key":"5014_CR27","doi-asserted-by":"publisher","first-page":"658524","DOI":"10.3389\/fphys.2021.658524","volume":"12","author":"B Szil\u00e1gyi","year":"2021","unstructured":"Szil\u00e1gyi B, Fejes Z, Ruszny\u00e1k \u00c1, Fenyvesi F, P\u00f3csi M, Halmi S, et al. Platelet Microparticles Enriched in miR-223 Reduce ICAM-1-Dependent Vascular Inflammation in Septic Conditions. Front Physiol. 2021;12:658524.","journal-title":"Front Physiol"},{"key":"5014_CR28","doi-asserted-by":"crossref","unstructured":"Bourgonje AR, Abdulle AE, Bourgonje MF, Kieneker LM, la, Bastide-van Gemert S, Gordijn SJ, et al. Plasma neutrophil gelatinase-associated lipocalin associates with new-onset chronic kidney disease in the general population. Biomolecules. 2023;13(2).","DOI":"10.3390\/biom13020338"},{"issue":"1","key":"5014_CR29","doi-asserted-by":"publisher","first-page":"21725","DOI":"10.1038\/s41598-025-06723-1","volume":"15","author":"B Behkamal","year":"2025","unstructured":"Behkamal B, Asgharian Rezae F, Mansoori A, Kolahi Ahari R, Mahmoudi Shamsabad S, Esmaeilian MR, et al. A machine learning-based framework for predicting metabolic syndrome using serum liver function tests and high-sensitivity C-reactive protein. Sci Rep. 2025;15(1):21725.","journal-title":"Sci Rep"},{"key":"5014_CR30","doi-asserted-by":"crossref","unstructured":"Chang JF, Hsieh CY, Liou JC, Lu KC, Zheng CM, Wu MS et al. Circulating p-cresyl sulfate, non-hepatic alkaline phosphatase and risk of bone fracture events in chronic kidney disease-mineral bone disease. Toxins. 2021;13(7).","DOI":"10.3390\/toxins13070479"},{"issue":"3","key":"5014_CR31","doi-asserted-by":"publisher","first-page":"sfaf040","DOI":"10.1093\/ckj\/sfaf040","volume":"18","author":"B Li","year":"2025","unstructured":"Li B, Zhao X, Luo S, Zhong Q, Zhao H, Du C, et al. Preoperative localization of parathyroid glands in secondary hyperparathyroidism: correlations between 99mTc-MIBI-SPECT\/CT, ultrasound, and pathological characteristics. Clin kidney J. 2025;18(3):sfaf040.","journal-title":"Clin kidney J"},{"key":"5014_CR32","doi-asserted-by":"crossref","unstructured":"Cai SY, Wang YM, Zhao YQ, Chi CF, Wang B. Cytoprotective effect of antioxidant pentapeptides from the protein hydrolysate of swim bladders of miiuy croaker (Miichthys miiuy) against H(2)O(2)-mediated human umbilical vein endothelial cell (HUVEC) injury. Int J Mol Sci. 2019;20(21).","DOI":"10.3390\/ijms20215425"},{"issue":"3","key":"5014_CR33","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1615\/CritRevImmunol.2023051651","volume":"44","author":"P Wan","year":"2024","unstructured":"Wan P, Tan X, Sheng M, Xiang Y, Wang P, Yu M. Platelet Exosome-Derived miR-223-3p Regulates Pyroptosis in the Cell Model of Sepsis-Induced Acute Renal Injury by Targeting Mediates NLRP3. Crit Rev Immunol. 2024;44(3):53\u201365.","journal-title":"Crit Rev Immunol"},{"key":"5014_CR34","doi-asserted-by":"publisher","first-page":"1013013","DOI":"10.3389\/fcvm.2022.1013013","volume":"9","author":"D Wei","year":"2022","unstructured":"Wei D, Tang L, Su L, Zeng S, Telushi A, Lang X, et al. Edgeworthia gardneri (Wall.) Meisn. extract protects against myocardial infarction by inhibiting NF-\u03baB-and MAPK-mediated endothelial inflammation. Front Cardiovasc Med. 2022;9:1013013.","journal-title":"Front Cardiovasc Med"},{"key":"5014_CR35","doi-asserted-by":"crossref","unstructured":"Keshavarz-Bahaghighat H, Darwesh AM, Sosnowski DK, Seubert JM. Mitochondrial dysfunction and inflammaging in heart failure: novel roles of CYP-derived epoxylipids. Cells. 2020;9(7).","DOI":"10.3390\/cells9071565"},{"key":"5014_CR36","doi-asserted-by":"crossref","unstructured":"Kang JH, Jang M, Seo SJ, Choi A, Shin D, Seo S, et al. Mechanobiological adaptation to hyperosmolarity enhances barrier function in human vascular microphysiological system. Adv Sci (Weinheim, Baden-Wurttemberg, Germany). 2023;10(13):e2206384.","DOI":"10.1002\/advs.202206384"},{"issue":"1","key":"5014_CR37","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s40001-024-01850-3","volume":"29","author":"J Luo","year":"2024","unstructured":"Luo J, Zhou Y, Song Y, Wang D, Li M, Du X, et al. Association between the neutrophil-to-lymphocyte ratio and in-hospital mortality in patients with chronic kidney disease and coronary artery disease in the intensive care unit. Eur J Med Res. 2024;29(1):260.","journal-title":"Eur J Med Res"},{"issue":"1","key":"5014_CR38","doi-asserted-by":"publisher","first-page":"284","DOI":"10.14336\/AD.2021.0617","volume":"13","author":"A Romero","year":"2022","unstructured":"Romero A, Dongil P, Valencia I, Vallejo S, Hip\u00f3lito-Luengo \u00c1S, D\u00edaz-Araya G, et al. Pharmacological Blockade of NLRP3 Inflammasome\/IL-1\u03b2-Positive Loop Mitigates Endothelial Cell Senescence and Dysfunction. Aging disease. 2022;13(1):284\u201397.","journal-title":"Aging disease"},{"key":"5014_CR39","doi-asserted-by":"publisher","first-page":"107388","DOI":"10.1016\/j.intimp.2021.107388","volume":"93","author":"S Hu","year":"2021","unstructured":"Hu S, Pi Q, Luo M, Cheng Z, Liang X, Luo S, et al. Contribution of the NLRP3\/IL-1\u03b2 axis to impaired vasodilation in sepsis through facilitation of eNOS proteolysis and the protective role of melatonin. Int Immunopharmacol. 2021;93:107388.","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"5014_CR40","first-page":"955","volume":"27","author":"K Lipiec","year":"2018","unstructured":"Lipiec K, Adamczyk P, \u015awi\u0119tochowska E, Ziora K, Szczepa\u0144ska M. L-FABP and IL-6 as markers of chronic kidney damage in children after hemolytic uremic syndrome. Advances in clinical and experimental medicine: official organ. Wroclaw Med Univ. 2018;27(7):955\u201362.","journal-title":"Wroclaw Med Univ"},{"key":"5014_CR41","doi-asserted-by":"crossref","unstructured":"Mohammad S, Mishra A, Ashraf MZ. Emerging role of vitamin D and its associated molecules in pathways related to pathogenesis of thrombosis. Biomolecules. 2019;9(11).","DOI":"10.3390\/biom9110649"},{"issue":"9","key":"5014_CR42","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1093\/ajh\/hpae060","volume":"37","author":"A Horvit","year":"2024","unstructured":"Horvit A, Jeon-Slaughter H, Sian J, Roehm B, Van Buren PN. Endothelin-1, Extracellular Volume Overload, and Hemodynamics in Hemodialysis Patients. Am J Hypertens. 2024;37(9):692\u20139.","journal-title":"Am J Hypertens"},{"key":"5014_CR43","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/jcm13195958","volume":"13","author":"B S\u00e1gi","year":"2024","unstructured":"S\u00e1gi B, Vas T, Jakabfi-Csepregi RK, Sulyok E, Csiky B. Association between Visit-to-Visit Ultrafiltration Volume Variability, Vascular Biomarkers and Cardiovascular Parameters in Chronic Hemodialysis Patients. J Clin Med. 2024;13:19.","journal-title":"J Clin Med"},{"issue":"1\u20132","key":"5014_CR44","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s11010-016-2723-0","volume":"417","author":"N Di Pietro","year":"2016","unstructured":"Di Pietro N, Giardinelli A, Sirolli V, Riganti C, Di Tomo P, Gazzano E, et al. Nitric oxide synthetic pathway and cGMP levels are altered in red blood cells from end-stage renal disease patients. Mol Cell Biochem. 2016;417(1\u20132):155\u201367.","journal-title":"Mol Cell Biochem"},{"key":"5014_CR45","doi-asserted-by":"publisher","first-page":"102195","DOI":"10.1016\/j.redox.2021.102195","volume":"48","author":"L Polito","year":"2021","unstructured":"Polito L, Bortolotti M, Battelli MG, Bolognesi A. Xanthine oxidoreductase: A leading actor in cardiovascular disease drama. Redox Biol. 2021;48:102195.","journal-title":"Redox Biol"},{"issue":"5","key":"5014_CR46","doi-asserted-by":"publisher","first-page":"405","DOI":"10.26502\/fccm.92920400","volume":"8","author":"I Batta","year":"2024","unstructured":"Batta I, Patial R, Sobti RC, Agrawal DK. Computational Biology in the Discovery of Biomarkers in the Diagnosis, Treatment and Management of Cardiovascular Diseases. Cardiol Cardiovasc Med. 2024;8(5):405\u201314.","journal-title":"Cardiol Cardiovasc Med"},{"key":"5014_CR47","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s40364-020-00221-4","volume":"8","author":"Y Xiao","year":"2020","unstructured":"Xiao Y, Xiao T, Ou W, Wu Z, Wu J, Tang J, et al. LncRNA SNHG16 as a potential biomarker and therapeutic target in human cancers. Biomark Res. 2020;8:41.","journal-title":"Biomark Res"},{"issue":"1","key":"5014_CR48","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12929-020-00647-w","volume":"27","author":"CF Yeh","year":"2020","unstructured":"Yeh CF, Chang YE, Lu CY, Hsuan CF, Chang WT, Yang KC. Expedition to the missing link: Long noncoding RNAs in cardiovascular diseases. J Biomed Sci. 2020;27(1):48.","journal-title":"J Biomed Sci"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-05014-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05014-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05014-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:13:14Z","timestamp":1783901594000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-05014-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,16]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5014"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-05014-9","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,16]]},"assertion":[{"value":"8 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study complies with the Declaration of Helsinki. The research protocol received approval from the Rongxian People\u2019s Hospital Ethics Committee (Approval number: RY2018-018), and every participant provided written informed consent before joining the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"412"}}